Publications by authors named "Doris Bach"

Claim this Profile
S
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex-VAD trial).
Anna Feuerstein, Felix Schoenrath, Evgeny Belyavskiy, Jan Knierim, Tim Friede, Doris Bach

Eur J Heart Fail· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental prognostic value of a novel metabolite-based biomarker score in congestive heart failure patients.
Peter McGranaghan, Hans-Dirk Düngen, Anshul Saxena, Muni Rubens, Joseph Salami, Doris Bach

ESC Heart Fail· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis.
Peter McGranaghan, Anshul Saxena, Muni Rubens, Jasmin Radenkovic, Doris Bach

Biomarkers· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
Susana Ravassa, Tobias Trippel, Doris Bach, Diana Bachran, Arantxa González

Eur J Heart Fail· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
Felix Hohendanner, David Bode, Uwe Primessnig, Tim Guthof, Rafael Doerr, Doris Bach

J Mol Cell Cardiol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Romana Urbas, Christian Mayr, Eckhard Klieser, Julia Fuereder, Doris Bach

Int J Mol Sci· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
Tomas Olsson, Aaron Boster, Óscar Fernández, Mark S Freedman, Carlo Pozzilli, Doris Bach

J Neurol Neurosurg Psychiatry· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
Tobias Kiesslich, Christian Mayr, Julia Wachter, Doris Bach, Julia Fuereder

Mol Cell Biochem· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Andrej Wagner, Christian Mayr, Doris Bach, Romana Illig, Kristjan Plaetzer

Int J Mol Sci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment.
Doris Bach, Julia Fuereder, Michael Karbiener, Marcel Scheideler, Anna Lena Ress

J Photochem Photobiol B· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
R Loch Macdonald, Randall T Higashida, Emanuela Keller, Stephan A Mayer, Andy Molyneux, Doris Bach

Acta Neurochir Suppl· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcutaneous vaccination via laser microporation.
Richard Weiss, Michael Hessenberger, Sophie Kitzmüller, Doris Bach, Esther E Weinberger

J Control Release· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling.
R Loch Macdonald, Randall T Higashida, Emanuela Keller, Stephan A Mayer, Andy Molyneux, Doris Bach

Stroke· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
R Loch Macdonald, Randall T Higashida, Emanuela Keller, Stephan A Mayer, Andy Molyneux, Doris Bach

Lancet Neurol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study.
Ekkehard Gruenig, Evangelos Michelakis, Jean-Luc Vachiéry, Carmine Dario Vizza, F Joachim Meyer, Doris Bach

J Clin Pharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.
Pamela Rendi-Wagner, Daniel Shouval, Blaise Genton, Yoav Lurie, Hans Rümke, Doris Bach

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis